Rebecca Critchley-Thorne
Gründer bei Cernostics, Inc.
Profil
Rebecca Critchley-Thorne is the founder and holds the title of Vice President-Research & Development at Cernostics, Inc. which is founded in 2008.
She also worked as a Senior Scientist at Acelerate, Inc. Dr. Critchley-Thorne earned a doctorate degree from Imperial College London.
Aktive Positionen von Rebecca Critchley-Thorne
| Unternehmen | Position | Beginn |
|---|---|---|
Cernostics, Inc.
 Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Gründer | 01.01.2008 |
Ehemalige bekannte Positionen von Rebecca Critchley-Thorne
| Unternehmen | Position | Ende |
|---|---|---|
Acelerate, Inc.
 Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rebecca Critchley-Thorne
| Imperial College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cernostics, Inc.
Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
Acelerate, Inc.
Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
